This is a timely opportunity to prepare for patient and prescriber questions
A high-potency antioxidant formulation featuring Nano Liposomal Glutathione blended with Vitamin C, designed to support detoxification, immune health, and cellular protection
The FDA lists BPC-157 among bulk drug substances that may present significant safety risks in compounding, citing concerns such as immune reactions, peptide-related impurities, and limited safety information
This precision approach aligns treatment selection with your unique biology, maximizing value regardless of when brand-name prices decline
it is the expected course of a chronic disease
Tirzepatide targets both receptors and is the active compound in Gala GLP-1's compounded treatment options